# NOVA Laboratory — continuation checkpoint (13 November 2026)

> This note anchors the ongoing work after the ChatGPT project conversation **«مواصلة الدردشة»**. It is a continuity reference, NOT a release approval, clinical certification, or claim of completed integration. Never use it to overwrite newer verified code or evidence.

## Scope and strict decisions
- Only NOVA Hospital laboratory is in scope. Keep the existing NOVA RTL interfaces and existing order/result/save/print flow. Do not rebuild the laboratory from scratch.
- Replace the old NOVA laboratory *catalogue*, not historical NOVA patient/order records, with **Royal Lab’s own 367 tests / 1,245 analytes**. Avoid old-NOVA name matching; use persistent source IDs and source-verified relationships.
- Preserve original clinical analyte titles, result types, active flags, dropdown option IDs and labels, unit IDs, reference ranges, source evidence and department ordering. Do not fabricate missing dropdowns, units, ranges, methods, or normal values from online examples.
- Do not migrate Royal Lab patients, results, old orders or prices.
- Do not expose Royal Lab technical source IDs/codes in end-user NOVA labels; keep them internally for audit and stable mapping.
- Do not alter NOVA pharmacy, its functioning thermal receipt printing, sales, stock, returns, other hospital modules or accepted lab A4 print behavior. Lab A4 should be portrait with patient header and results on one coherent report, without 'partial report' boilerplate.
- Make reversible/idempotent catalogue installation; no destructive production changes without verified preflight/backups/rollback.
- User preference: finish practical fixes in large, carefully tested batches; avoid many low-content progress reports, repeated reuploads, or repetitive questions.

## Repositories / reference points
- NOVA repo: `megdad234/nova-hospital-test`
- NOVA feature branch: `feature/royallab-full-migration-20261111`; keep `main` untouched.
- Original source: private `megdad234/Royallab-Recovery`, branch `recovered-results`, backed by original `RoyalLabDB.bak`.
- Bundled NOVA source: `hospital/royallab_source/nova_lab_library.json` (original user-supplied ~3 MB library available in repository; do not demand reupload without actual necessity).
- Existing design/validation evidence: `docs/ROYALLAB_NOVA_MIGRATION_MASTER_PLAN.md`, `docs/ROYALLAB_REAL_DATA_VALIDATION_2026-11-11.md`.
- Useful implementation: `hospital/royallab_catalog_audit.py`, `hospital/royallab_native_catalog_store.py`, `hospital/royallab_field_adapter.py`, `hospital/royallab_clinical_template_review.py`, `hospital/royallab_missing_test_review_templates.py` and `tests/test_royallab_*.py`.
- Last inspected pre-checkpoint commit: `555b57902fdfada93039d9eae78f19de44766f48` (12 November 2026); read-only audit workflow 43313804043 completed successfully. This is not proof of an accepted or installed production Windows setup.

## Source evidence already verified
- 367 source tests, 1,245 analytes, original 1,493 result formats.
- 10,108 linked dropdown options; **2,551 unlinked choices** preserved separately (not blindly attached). Source integrity records include 64 analytes referring to missing parent test IDs; source-verified numeric format subtype mapping is implemented separately.
- Source recovery `output/nova_library/validation.json` reports 63 tests with no candidate analytes, 36 with partial coverage, and 87 requiring review under the previous staging rules. Do not confuse audit flags with current runtime-blocked count; re-run `python -m hospital.royallab_catalog_audit` on HEAD for current counts.
- Follow-up source-only audit 13 Nov: `output/nova_library/test_coverage_report.json` contains **57 tests with zero source analytes**; the source recovery has **66 historical per-test result-table CSV files** named `dbo__Test_<ID>.csv`, **none for those 57 IDs**. Historical result tables do exist for some partially represented forms (examples: test 7 Urine; 8 Stool; 13 malaria; 21 CBC; 60 HbA1c). Thus do not claim historical result tables can reconstruct missing tests when no matching table exists. Read *headers / IDs only* if studying evidence; never copy patient result rows into NOVA or public repo.
- Legacy archived `dbo__Test_60.csv` includes an HbA1c result-column identifier even though original HbA1c analyte fields are inactive. This **does not authorize reactivating** them. The current independent clinical review/test guard enforces inactive source fields stay review-only until local documented approval.
- Cases with absent source evidence must remain explicitly reviewable, not silently guessed. Any kit-specific selectable choices must come from the actual local assay and verified source or an independent clinical method review, not generic internet lists.

## Next implementation priorities (not claims of completed work)
1. Re-run current branch's source audit and classify runtime-blocked tests by exact cause, separating non-laboratory services, inactive/blank separators, true missing analyte/format/option links, unsupported field types, and missing local method evidence.
2. For partial tests with `dbo__Test_<ID>` tables, compare **schema-only** `AnalyteResult_<analyteID>_<resultformatID>` headers to source `dbo__Analyte.csv` / `dbo__ResultFormat.csv`. Propose only exact-ID source links; do not infer by similar name or copy results.
3. Retain source-proven dropdowns. For genuinely missing closed-format links/options, show a safe review/draft path instead of fabricated choices; enforce review by independently authorized clinical staff before clinical activation.
4. End-to-end verify NOVA order picker → typed result input → save/reopen/edit → A4 print for CBC, urine, stool, malaria, culture/sensitivity, plus incomplete-test behavior and service exclusions. Preserve pharmacy unchanged.
5. Re-run Windows Actions build and tests; inspect actual installer contents and installed workflow. Hand over `Setup.exe` only after real verified build and acceptance evidence. No premature "all done" assertion.

## Verified latest conversation checkpoint: 12 Nov 2026, after in-app review implementation
This subsection supersedes the earlier *source-only* priority wording above where it might imply that the review UI or Windows build has not yet been attempted.

- The user confirmed the final previous-chat milestone: **a live in-NOVA Arabic RTL review/repair UI for blocked forms**, not merely standalone review exports. In `hospital/static/royallab-native-picker.js`, the panel is titled `إصلاح نماذج الفحوصات الناقصة (يتطلب مراجعة مستقلة)` and contains test selection, source-prefill, text/number/select fields, units, choices, local method/evidence/rationale, submission and review history. The related API and clinical review services are present. These functions are **implemented in source**, but a full latest-version live GUI acceptance test remains distinct.
- The review path requires independent second-person administrator sign-off, blocks a proposer from self-approving, preserves historical source definitions and existing patient drafts, and never automatically activates guessed kit-specific dropdowns, units or normal ranges. Review-only suggestion may include inactive original fields with explicit warnings, but must not reactivate them without review.
- Chat progression reported 179 then 181, 183, and finally **186 automated tests passed**; these are sequential test milestones, not test IDs. Last conversation-reported catalogue state: **303 ready / 330 clinical laboratory tests, 27 requiring review**, with the difference to 367 representing non-clinical service entries. Distinguish *runtime-blocked tests (27)* from older staging metrics such as 57 zero-analyte tests, 63 no-candidate tests, or 87 review flags. Recompute these figures after any further code change.
- Seminal Culture: verified dash-only historical separators are excluded from editable results, while source metadata stays for audit. Whole Blood: nameless/no-format placeholders do not block real analyte entry. Original HbA1c inactive fields may only enter review suggestions and stay inactive before approval.
- Last substantive code commit found: `555b57902fdfada93039d9eae78f19de44766f48` at 2026-11-12 21:48 UTC. Read-only source audit run `43313804043` passed. The later `bd7969c8` commit modifies only this continuation document, not lab runtime code.
- **A Windows DEVELOPMENT installer build exists and passed CI**, contradicting earlier wording that no Windows build had happened: workflow `43313418357`, completed successfully on 2026-11-12 21:53 UTC; its build used earlier code SHA `bf4622f252cbbda3717b8a5cc1c24acf4efdb89f`. The job included fresh installer compilation and synthetic install/upgrade/rollback checks. Artifact `NOVA-Hospital-Windows-Setup-DEV-UNAPPROVED` (ID `13986653751`) was published. **This is not the final accepted installer**, because more source commits followed that build; rerun the Windows build on current HEAD, inspect its results and test complete lab UI, saving, and A4 print before release.
- The correct immediate next step is therefore to finish verified gaps for the remaining 27 clinical forms, preserve the implemented Arabic review workflow, run the newest comprehensive checks, and produce a current-HEAD Windows installer. Do NOT restart catalog extraction, rebuild the review system from scratch, or change the pharmacy / existing print logic.

## متابعة صور المعمل الأصلية — 13 نوفمبر 2026 (بعد مراجعة الكود)
- صور المستخدم من نظام Royal Lab الأصلي الحقيقي في المعمل؛ استخدمت لقراءة الحقول **من دون نسخ صور أو بيانات مرضى إلى GitHub**.
- بعد مراجعة الكود: NOVA **يدعم بالفعل** text/number/select/mixed select-or-number-or-text، ويحتفظ بعدة ResultFormats منفصلة لنفس analyte. اختبارات الـUrine تؤكد أنها لا تُدمج في Dropdown واحد، ولذلك لا تعِد برمجة ما هو موجود.
- تم تنفيذ `hospital/royallab_source_sibling_review.py`: مقارنة نماذج المصدر الأصلية للأرقام المحددة مع الفحوص الناقصة، بلا اعتماد أو دمج أو تعديل بيانات المرضى: 320↔101 (CBC Five Differential لا 21)، 287↔292 (Cholera O1/O139)، 336↔337 (HCV ولكن طرق مختلفة وللقراءة فقط)، 347↔309 (Typhoid ICT لا Widal)، 368↔316 (Vitamin D)، 391↔89/315 (B12)، مع حالات إضافية ذات صلة فقط. النوع/الوحدة/المدى الخاص بالكيت يحتاج التحقق المحلي.
- `hospital/royallab_clinical_template_review.py` يرجع الآن `related_source_forms` للواجهة العربية الأصلية. `hospital/static/royallab-native-picker.js` يعرضها كمرجع مع زر اختيار صريح لنقل الحقول إلى **مسودة غير معتمدة** عندما يكون النموذج مناسباً. لا تعديل آلي على الحقول المكتوبة، ولا نسخ آلي لنتائج HCV متعددة الطرق أو عناصر Cholera O1/O139 أو Blood Sugar Curve.
- حماية إضافية في `tests/test_royallab_source_sibling_review.py` و`tests/test_royallab_existing_line_overlay.py`: بقاء معرفات الحقول متعددة الصيغ منفصلة؛ كل نموذج مرتبط بهوية المصدر الأصلية؛ لا اعتماد تلقائي ولا تعديل على فحوص أخرى.
- فحص المعمل الأصلي نجح (193 اختباراً، فضلاً عن 10 لاختبار إدارة الفحوص المحلية) في GitHub Actions `43325329990`. يجب إعادة تدقيق أحدث CI بعد أي تغيير لاحق.
- التفاصيل الطبية والفنية دون أسماء مرضى في `docs/ROYALLAB_ORIGINAL_SCREENS_NOVA_RECONCILIATION_2026-11-13_AR.md`.
- **المتبقي سريرياً:** كما في التدقيق الأصلي 303/330 فحوص قابلة للإدخال و27 تحتاج مراجعة، منها 20 بلا analytes أصلية و7 مشكلات أخرى. وجود مرجع قريب داخل Royal Lab لا يزيل الحاجة لتحديد الكيت أو طريقة القياس أو اعتماد شخص آخر، ولا يفتح الفحص تلقائياً.
- البناء Windows من أحدث تعديلات الكود قيد التحقق في Run `43325867517` عند كتابة هذه الإضافة؛ لا توصف الحزمة إنتاجية أو معتمدة قبل نجاح اختبارات التثبيت والترقية والتراجع وتجربة بيئة المعمل الحقيقية.
